---
title: "Baiyunshan Pharmaceutical Passes Generic Drug Consistency Evaluation for Bone Drug"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275266544.md"
description: "Baiyunshan Pharmaceutical Passes Generic Drug Consistency Evaluation for Bone Drug"
datetime: "2026-02-09T05:09:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275266544.md)
  - [en](https://longbridge.com/en/news/275266544.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275266544.md)
---

# Baiyunshan Pharmaceutical Passes Generic Drug Consistency Evaluation for Bone Drug



### Related Stocks

- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [516610.CN](https://longbridge.com/en/quote/516610.CN.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [00874.HK](https://longbridge.com/en/quote/00874.HK.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [600332.CN](https://longbridge.com/en/quote/600332.CN.md)

## Related News & Research

- [RemeGen Drug Approved For Cancer Indication](https://longbridge.com/en/news/282478668.md)
- [Ascletis Pharma Selects Oral Obesity Drug Combination for Clinical Development](https://longbridge.com/en/news/281968452.md)
- [Faron raises EUR 40.1 million in rights issue to advance cancer drug bexmarilimab](https://longbridge.com/en/news/282233028.md)
- [AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid](https://longbridge.com/en/news/282533515.md)
- [Fosun Pharma Unit Gets China Nod for Amyloidosis Drug Trial](https://longbridge.com/en/news/282675084.md)